Cyclophosphamide monohydrate
SIGMA/C7397 - ISOPAC®
Synonym: 2-
CAS Number: 6055-19-2
Empirical Formula (Hill Notation): C7H15Cl2N2O2P · H2O
Molecular Weight: 279.10
EC Number: 200-015-4
MDL Number: MFCD00149395
Linear Formula: C7H15Cl2N2O2P · H2O
Product Type: Chemical
| assay | 97.0-103.0% (HPLC) |
| form | powder |
| InChI | 1S/C7H15Cl2N2O2P.H2O/c8-2 |
| InChI key | PWOQRKCAHTVFLB-UHFFFAOYSA |
| mp | 49-51 °C (lit.) |
| Quality Level | 100 ![]() |
| SMILES string | [H]O[H].ClCCN(CCCl)P1(=O) |
| storage temp. | 2-8°C |
| Application: | Cyclophosphamide, a nitrogen mustard DNA alkylating agent, is used to study its mechanisms of action as an anticancer and antiimmunity drug. |
| Biochem/physiol Actions: | Cyclophosphamide is a cytotoxic nitrogen mustard derivative widely used in cancer chemotherapy. It cross-links DNA, causes strand breakage, and induces mutations. Its clinical activity is associated with a decrease in aldehyde dehydrogenase 1 (ALDH1) activity. |
| Biochem/physiol Actions: | Cytotoxic nitrogen mustard derivative widely used in cancer chemotherapy. It cross-links DNA, causes strand breakage, and induces mutations. |
| Disclaimer: | Injecting a compatible solvent directly into the vial permits preparation of any desired strength solution without exposure. |
| Legal Information: | Isopac is a registered trademark of Merck KGaA, Darmstadt, Germany |
| Packaging: | 1 g in serum bottle |
| Packaging: | Packaged in a 100 mL serum bottle with silicon/PTFE septum and aluminum tear seal. |
| Preparation Note: | Dissolving the contents in 100 mL of solvent yields a 1% solution. |
| Symbol | ![]() GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H301 - H340 - H350 - H360FD |
| Precautionary statements | P202 - P264 - P270 - P280 - P301 + P310 - P405 |
| Hazard Codes | T |
| Risk Statements | 45-25 |
| Safety Statements | 53-45 |
| RIDADR | UN 3464 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Purity | 97.0-103.0% (HPLC) |
| mp | 49-51 °C (lit.) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51112507 |



